SCOPUS 정보 검색 플랫폼

Gastroenterology

Volumn 133, Issue 5, 2007, Pages 1743-1744

Australian Crohn's Antibiotic Study Opens New Horizons

(2) Gitlin, Laura a Biesecker, James b

a Gastroenterology Institute (United States)

b BBC Biochemical Inc (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; INFLIXIMAB; METRONIDAZOLE; RIFABUTIN;

ANTIBIOTIC THERAPY; COMBINATION CHEMOTHERAPY; CROHN DISEASE; HUMAN; LETTER; MYCOBACTERIUM AVIUM; PRIORITY JOURNAL; REMISSION;

ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; CLARITHROMYCIN; CLOFAZIMINE; CROHN DISEASE; DRUG THERAPY, COMBINATION; GASTROINTESTINAL AGENTS; HUMANS; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; PARATUBERCULOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; REPRODUCIBILITY OF RESULTS; RIFABUTIN; TREATMENT OUTCOME;

EID: 35648952284 PISSN: 00165085 EISSN: None Source Type: Journal
DOI: 10.1053/j.gastro.2007.09.014 Document Type: Letter

Times cited : (17)

References (8)

1
- 34250030068
- Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease
- Selby W., Pavli P., Crotty B., et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology 132 (2007) 2313-2319
- (2007) Gastroenterology , vol.132 , pp. 2313-2319
- Selby, W.¹ Pavli, P.² Crotty, B.³

2
- 35648986150
- ICH Harmonised Tripartite Guideline: General Considerations for Clinical Trials E8.

3
- 0036161216
- A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
- Sandborn W.J., Feagan B.G., Hanauer S.B., et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 122 (2002) 512-530
- (2002) Gastroenterology , vol.122 , pp. 512-530
- Sandborn, W.J.¹ Feagan, B.G.² Hanauer, S.B.³

4
- 35648968670
- Continuing medical education exam 2
- Continuing medical education exam 2. Gastroenterology 132 (2007) 2578-2579
- (2007) Gastroenterology , vol.132 , pp. 2578-2579

5
- 0042708022
- Is Crohn's disease caused by a mycobacterium?. Comparisons with leprosy, tuberculosis, and Johne's disease
- Greenstein R.J. Is Crohn's disease caused by a mycobacterium?. Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet 3 (2003) 507-514
- (2003) Lancet , vol.3 , pp. 507-514
- Greenstein, R.J.¹

6
- 33746122749
- Severe recurrent Crohn's disease of ileocolonic anastomosis and antimicrobial (anti-mycobacterial) therapy
- Borody T.J., and Heifets L.B. Severe recurrent Crohn's disease of ileocolonic anastomosis and antimicrobial (anti-mycobacterial) therapy. Gut 55 (2006) 1211
- (2006) Gut , vol.55 , pp. 1211
- Borody, T.J.¹ Heifets, L.B.²

7
- 33847297550
- Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis
- Chamberlin W., Ghobrial G., Chehtane M., et al. Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis. Am J Gastroenterol 102 (2006) 689-691
- (2006) Am J Gastroenterol , vol.102 , pp. 689-691
- Chamberlin, W.¹ Ghobrial, G.² Chehtane, M.³

8
- 33947718717
- Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars
- Borody T.J., Bilkey S., Wettstein A.R., et al. Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars. Dig Liver Dis 39 (2007) 438-444
- (2007) Dig Liver Dis , vol.39 , pp. 438-444
- Borody, T.J.¹ Bilkey, S.² Wettstein, A.R.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.